← The Wire
EDSANasdaq
Edesa Biotech, Inc.
Pharmaceutical Preparations · A1 · CIK 1540159
Edesa Biotech develops innovative drug candidates for inflammatory and immune-related diseases, focusing on dermatology and respiratory conditions
red 8-K · 90d
$52M
Market cap
$7.67
Last close
-6.3%
1D
+12.6%
5D
75K
Volume
Price · last 39 sessions-52.4%
May 4L $4.94 · H $17.43Jun 29
341
Total filings
Jun 11, 2026
Last filing
09/30
Fiscal year end
SC 13D/ASC 13D/AJun 16, 20268-KMaterial Agreement · Equity IssuanceJun 11, 20268-KCompany UpdateJun 5, 20268-KExecutive Change · Shareholder VoteMay 29, 20268-KExecutive ChangeMay 15, 202610-QFORM 10-QMay 14, 20268-KResults of OperationsMay 14, 2026DEFA14ADEFA14AApr 3, 2026DEF 14AFORM DEF 14AApr 3, 2026SC 13D/ASC 13D/AMar 2, 2026SC 13D/ASC 13D/AMar 2, 20268-KCompany UpdateFeb 24, 202610-QFORM 10-QFeb 13, 20268-KResults of OperationsFeb 13, 20268-KCompany UpdateDec 12, 2025424B5424B5Dec 12, 202510-KFORM 10-KDec 12, 20258-KResults of OperationsDec 12, 20258-KCompany UpdateOct 28, 20258-KMaterial Agreement · New Debt / ObligationSep 30, 20258-KCompany UpdateSep 9, 2025424B5424B5Sep 9, 202510-QFORM 10-QAug 8, 20258-KResults of OperationsAug 8, 20258-KExecutive Change · Shareholder VoteMay 28, 202510-QFORM 10-QMay 14, 20258-KResults of OperationsMay 14, 2025DEFA14AFORM DEFA14AApr 4, 2025DEF 14ADEFINITIVE PROXY STATEMENTApr 4, 20258-KExecutive Change · Company UpdateApr 4, 202510-QFORM 10-QFeb 14, 20258-KResults of OperationsFeb 14, 20258-KExecutive Change · Material AgreementFeb 13, 202510-K/AFORM 10-K/ADec 20, 202410-KFORM 10-KDec 13, 20248-KResults of OperationsDec 13, 20248-KMaterial Agreement · Agreement TerminatedOct 31, 2024424B5424B5Oct 4, 20248-KMaterial Agreement · Agreement TerminatedOct 4, 202410-QFORM 10-QAug 9, 20248-KResults of OperationsAug 9, 20248-KReg FD Disclosure · Company UpdateJun 24, 2024SC 13GSC 13GJun 3, 20248-KExecutive ChangeMay 30, 202410-QFORM 10-QMay 10, 20248-KResults of OperationsMay 10, 2024DEFA14ADEFA 14AApr 5, 2024DEF 14ADEF 14AApr 5, 202410-QFORM 10-QFeb 9, 20248-KResults of OperationsFeb 9, 202410-KFORM 10-KDec 15, 20238-KResults of OperationsDec 15, 20238-KCompany UpdateOct 26, 20238-KMaterial Agreement · New Debt / ObligationOct 23, 20238-KMaterial Agreement · New Debt / ObligationOct 12, 20238-KSecurity-Holder Rights · Company UpdateOct 11, 202310-QFORM 10-QAug 9, 20238-KResults of OperationsAug 9, 20238-KExecutive ChangeJun 27, 20238-KDelisting NoticeJun 23, 20238-KExecutive Change · Shareholder VoteMay 24, 202310-QFORM 10-QMay 11, 20238-KResults of OperationsMay 11, 2023DEF 14AFORM DEF 14AMar 28, 20238-KMaterial AgreementMar 27, 2023424B5424B5Mar 27, 202310-K/AFORM 10-K/AMar 27, 20238-KReg FD DisclosureMar 13, 202310-QFORM 10-QFeb 10, 20238-KResults of OperationsFeb 10, 2023SC 13GSC 13GJan 6, 202310-KFORM 10-KDec 16, 20228-KResults of OperationsDec 16, 20228-KMaterial Agreement · Equity IssuanceNov 3, 202210-QFORM 10-QAug 12, 20228-KResults of OperationsAug 12, 20228-KShareholder VoteMay 20, 202210-QFORM 10-QMay 13, 20228-KResults of OperationsMay 13, 2022424B4424B4Apr 19, 2022
Insider Activity
◆ Cluster Buy · 2 insidersIn the 90 days to Mar 10, 2026: 2 insiders bought $233K.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 10, 2026 | Nijhawan PardeepChief Executive Officer | Buy | 1,000 | $6.60 | $7K |
| Mar 5, 2026 | Nijhawan PardeepChief Executive Officer | Buy | 10,000 | $3.90 | $39K |
| Mar 4, 2026 | Nijhawan PardeepChief Executive Officer | Buy | 10,000 | $4.26 | $43K |
| Mar 3, 2026 | Nijhawan PardeepChief Executive Officer | Buy | 10,000 | $3.63 | $36K |
| Mar 2, 2026 | Nijhawan PardeepChief Executive Officer | Buy | 2,000 | $2.00 | $4K |
| Mar 2, 2026 | Nijhawan PardeepChief Executive Officer | Buy | 1,000 | $2.28 | $2K |
| Feb 27, 2026 | Nijhawan PardeepChief Executive Officer | Buy | 30,000 | $2.22 | $67K |
| Feb 26, 2026 | Nijhawan PardeepChief Executive Officer | Buy | 20,571 | $1.58 | $33K |
| Feb 26, 2026 | Brooks Michael JPresident | Buy | 2,000 | $1.57 | $3K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.
Similar companies
Comparable business profile · signals at a glance